Title : A Novel Combination of the mTORC1 Inhibitor Everolimus and the Immunomodulatory Drug Lenalidomide Produces Durable Responses in Patients With Heavily Pretreated Relapsed Lymphoma.

Pub. Date : 2018 Oct

PMID : 30104176






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 A Novel Combination of the mTORC1 Inhibitor Everolimus and the Immunomodulatory Drug Lenalidomide Produces Durable Responses in Patients With Heavily Pretreated Relapsed Lymphoma. Everolimus CREB regulated transcription coactivator 1 Mus musculus